Reuters: Health
Drugmaker Polyphor is hiring new managers and shifting focus after a trial of its top antibiotic hopeful proved too dangerous to continue, the Swiss company said on Wednesday.
Polyphor reinvents itself after abandoning antibiotic trial
Polyphor reinvents itself after abandoning antibiotic trial
Reuters: Health
Drugmaker Polyphor is hiring new managers and shifting focus after a trial of its top antibiotic hopeful proved too dangerous to continue, the Swiss company said on Wednesday.
Reuters: Health
Drugmaker Polyphor is hiring new managers and shifting focus after a trial of its top antibiotic hopeful proved too dangerous to continue, the Swiss company said on Wednesday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment